X

Vivo Bio Tech Ltd Stock Analysis

Small Cap
Evaluated by 96 users | BSE: 511509 | NSE: |
Miscellaneous
Vivo Bio Tech was incorporated on February 12, 1987 as Golden Growth Fund, Hyderabad-based Vivo Bio Tech (VBTL) is a contract research company engaged in biotechnology and pharma drug discovery activities. The company was converted into a public limited company from Jun. 19, 1992. VBTL...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 1.76%11.26%4.73%4.21%5.51%5.95%10.23%11.42%8.89%12.77%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 9.512.514.416.117.828.634.14755.855.4
Y-o-Y Gr. Rt.-30.8%15.1%12.3%10.3%60.7%19.4%37.7%18.8%-0.9%
Adjusted EPS (Rs.) -1.660.760.420.310.50.982.683.191.873.47
Y-o-Y Gr. Rt.-NA-44.7%-26.2%61.3%96%173.5%19%-41.4%85.6%
Book Value per Share (Rs.) 4.465.238.789.099.7810.7413.4517.4521.7725.59
Adjusted Net Profit -1.60.70.40.30.50.92.53.12.34.5
Net Op. Cash Flow (Rs. Cr.) 3.24.72.12.82.18.7-5.711.1-0.87.7
Debt to Cash Flow from Ops 7.214.911.692.382.681.94-4.792.26-27.492.86
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Vivo Bio Tech Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 21.6%25.5%17.5%-0.9%
Adjusted EPS NA47.3%9%85.6%
Book Value per Share 21.421.223.917.6
Share Price - 8% -1.5% 133.3%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) -31.1515.495.983.495.289.5422.119.79.8914.84
Operating Profit Margin (%) 40.2942.4516.4710.8415.8113.0122.3723.2217.1822.62
Net Profit Margin (%) -16.285.672.741.812.633.217.346.694.138.09
Debt to Equity 5.474.690.440.780.621.682.151.460.810.67
Working Capital Days 129204193179199138155165158170
Cash Conversion Cycle -655-401-240-228-41-45-11375381
Entity Percentage Holding
Promoters 34.70%
Non-Institutions 65.30%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Vivo Bio Tech Ltd's performance infers:

Vivo Bio Tech Ltd earnings have grown by 47.3%, whereas share price has appreciated 8% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

Data is not available for this company

Vivo Bio Tech was incorporated on February 12, 1987 as Golden Growth Fund, Hyderabad-based Vivo Bio Tech (VBTL) is a contract research company engaged in biotechnology and pharma drug discovery activities. The company was converted into a public limited company from Jun. 19, 1992. VBTL provides services ranging from insilico design, wet lab contract research, preclinical research and clinical studies spanning the entire drug discovery value chain.

It is a full service CRO offering drug

Vivo Bio Tech was incorporated on February 12, 1987 as Golden Growth Fund, Hyderabad-based Vivo Bio Tech (VBTL) is a contract research company engaged in biotechnology and pharma drug discovery activities. The company was converted into a public limited company from Jun. 19, 1992. VBTL provides services ranging from insilico design, wet lab contract research, preclinical research and clinical studies spanning the entire drug discovery value chain.

It is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of custom research, In-vitro and In-vivo toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. Tailored and dedicated to our clients, we distinguish your development plan is as superlative as the products you bring to our testing facilities.

The Custom Research Services group at Vivo Bio Tech offers a complete line of protein services, including gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. Our scientists will team up with you to develop solution for the most difficult to deal products including purification of untagged & poorly expressed proteins.

In-vitro Services offers solutions for pharmacologic, toxicological & bioanalytical investigations in drug discovery & development. Critical investigations like bacterial reverse mutation assays, chromosomal aberration, and micronucleus are specialty services by our scientists.

Vivo Bio Tech has obtained permission from the Govt. of India for developing Biotech Sector Specific 'Special Economic Zone' at its site (39 acres) in Pregnapur, Gajwel Mandal, Medak District, Andhra Pradesh.The Vivo Bio Tech SEZ is located adjacent to Karimnagar highway road (approx 16 km from ICICI Knowledge Park and SP Biotech Park). The site is approximately 53km from Secunderabad Railway Station and around 90km from the new airport (Shamshabad).

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback